{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:54:15Z","timestamp":1791179655425,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Depression imposes a substantial global disease burden. Current pharmacotherapies are often limited by a delayed onset of action, significant adverse effects, and high costs. Preclinical studies have indicated that artemisinin and its derivatives possess neuroprotective and anti-inflammatory properties and have demonstrated antidepressant-like effects in rodent models. However, no meta-analysis has yet been performed on these preclinical rodent studies. This study aimed to systematically evaluate the antidepressant efficacy of artemisinin in rodent models of depression-like behavior and to identify potential factors influencing the variability in treatment effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study systematically searched four databases (PubMed, Web of Science, Embase, and China National Knowledge Infrastructure), including randomized controlled trials (RCTs) published up to May 2026. All data were statistically analyzed using a random-effects model, yielding standardized mean differences (SMDs) with their 95% confidence intervals (CIs). Subgroup analyses were conducted based on rodent species, depression-like modeling methods, intervention timing, duration, and frequency. Publication bias was assessed using Egger\u2019s test, funnel plots, and trim-and-fill analyses. Sensitivity analyses were performed to evaluate result robustness. The risk of bias was evaluated using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool, and the overall certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 17 studies involving 402 rodents were included in the analysis. Compared with the control group, artemisinin reduced immobility in the TST and FST, increased sucrose preference in the SPT, alleviated anxiety-like behaviors in the OFT and EPM, and improved cognitive performance in the MWM, Y-maze, and NOR. Subgroup analyses identified intervention duration, frequency, species, modeling methods, and derivative type as impactful moderators. Sensitivity tests validated stable outcomes. While Egger\u2019s test hinted at publication bias in the OFT, TST, and FST datasets, trim-and-fill analyses imputed zero missing studies, although this does not fully exclude publication bias given the limited number of studies. Under the GRADE framework, the certainty of evidence was rated as very low for most outcomes due to high risk of bias, substantial heterogeneity, and indirectness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Artemisinin can ameliorate depression-like and anxiety-like behaviors and improve cognitive function. These findings provide a basis for further investigation into artemisinin as an adjunctive therapeutic agent for depression. However, the certainty of evidence is very low due to methodological limitations in the included preclinical studies, and additional clinical trials are required to evaluate its efficacy in humans.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1916381","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:46Z","timestamp":1791178366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuan","family":"Tian","sequence":"first","affiliation":[{"name":"Sichuan Provincial Center for Mental Health, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sichuan Provincial Center for Mental Health, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sichuan Provincial Center for Mental Health, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[{"name":"Sichuan Provincial Center for Mental Health, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0003-3472(73)80065-x","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim. Behav."},{"key":"B2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res. Synth. Methods"},{"key":"B4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.12740\/PP\/OnlineFirst\/105415","article-title":"Cognitive dysfunctions in depression - significance, description and treatment prospects","volume":"54","author":"Czerwi\u0144ska","year":"2020","journal-title":"Psychiatr. Pol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/1871524911106040285","article-title":"Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research","volume":"11","author":"de Miranda","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"116800","DOI":"10.1016\/j.jep.2023.116800","article-title":"Effects of Artemisia annua L. on postmenopausal syndrome in ovariectomized mice","volume":"317","author":"Do Yeon","year":"2023","journal-title":"J. Ethnopharm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jama.263.10.1385","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA J. Am. Med. Ass."},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e8315","DOI":"10.5867\/medwave.2021.06.8315","article-title":"Introduction to network meta-analysis for evidence synthesis","volume":"21","author":"Gonz\u00e1lez-Xuriguera","year":"2021","journal-title":"Medwave"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1101","DOI":"10.1371\/journal.pone.0001101","article-title":"A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru","volume":"2","author":"Grande","year":"2007","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.genhosppsych.2008.10.004","article-title":"alpha\/beta-arteether-induced mania in a predisposed adolescent","volume":"31","author":"Haq","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"104769","DOI":"10.1016\/j.bioorg.2021.104769","article-title":"Synergistic integration of dihydro-artemisinin with \u03b3-aminobutyric acid results in a more potential anti-depressant","volume":"110","author":"He","year":"2021","journal-title":"Bioorg Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a lancet-world psychiatric association commission","volume":"399","author":"Herrman","year":"2022","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ilar\/ilu042","article-title":"Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare","volume":"55","author":"Hooijmans","year":"","journal-title":"ILAR J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"","journal-title":"BMC Med. Res. Methodol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2833","DOI":"10.1002\/brb3.2833","article-title":"Repurposing antimalarial artesunate for the prophylactic treatment of depression: evidence from preclinical research","volume":"13","author":"Huang","year":"2023","journal-title":"Brain Behav."},{"key":"B16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"B17","first-page":"470","article-title":"Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased","volume":"316","author":"Irwig","year":"1998","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1352827","DOI":"10.3389\/fphar.2024.1352827","article-title":"Pre-clinical studies comparing the anti-inflammatory potential of artemisinic compounds by targeting NF\u03baB\/TNF-\u03b1\/NLRP3 and Nrf2\/TRX pathways in Balb\/C mice","volume":"15","author":"Kazmi","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00706-021-02759-x","article-title":"Antimalarial and anticancer properties of artesunate and other artemisinins: current development","volume":"152","author":"Khanal","year":"2021","journal-title":"Monatsh Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1642167","DOI":"10.3389\/fphar.2025.1642167","article-title":"Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"120308","DOI":"10.1016\/j.jep.2025.120308","article-title":"From network prediction to experimental validation: multi-target mechanisms of Artemisia absinthium L. Essential Oil (AAEO) against depression","volume":"353","author":"Liu","year":"2025","journal-title":"J. Ethnopharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.4103\/1673-5374.255960","article-title":"More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration","volume":"14","author":"Lu","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0140-6736(13)62329-6","article-title":"Biomedical research: increasing value, reducing waste","volume":"383","author":"Macleod","year":"2014","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12916-018-1101-z","article-title":"The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses","volume":"16","author":"Machado","year":"2018","journal-title":"BMC Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12936-016-1391-6","article-title":"Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives","volume":"15","author":"Nevin","year":"2016","journal-title":"Malar. J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1000344","DOI":"10.1371\/journal.pbio.1000344","article-title":"Publication bias in reports of animal stroke studies leads to major overstatement of efficacy","volume":"8","author":"Sena","year":"2010","journal-title":"PLoS Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12991-020-00292-5","article-title":"The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey","volume":"19","author":"Tandon","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2023.11.029","article-title":"Dihydroartemisinin protects mice from CUMS-induced depression-like behaviors by regulating gut microbes","volume":"547","author":"Tang","year":"2024","journal-title":"Neuroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12887-024-05265-1","article-title":"The role of breastfeeding, antibiotics and antimalarial medicinal exposure in paediatric depression amongst children aged under 5: a population-based study","volume":"25","author":"Umeh","year":"2025","journal-title":"BMC Pediatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","article-title":"Meta-analysis of data from animal studies: a practical guide","volume":"221","author":"Vesterinen","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2003693","DOI":"10.1371\/journal.pbio.2003693","article-title":"Reproducibility of preclinical animal research improves with heterogeneity of study samples","volume":"16","author":"Voelkl","year":"2018","journal-title":"PLoS Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1192\/bjpo.bp.116.002766","article-title":"Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study","volume":"2","author":"Whale","year":"2016","journal-title":"BJPsych Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/pgmj.2004.028399","article-title":"Artemisinins","volume":"81","author":"Woodrow","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1142\/S0192415X24500642","article-title":"The potential role of artemisinins against neurodegenerative diseases","volume":"52","author":"Xia","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.3390\/ijms26178409","article-title":"Artemisinin and its derivatives from molecular mechanisms to clinical applications: New Horizons beyond antimalarials","volume":"26","author":"Xia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/molecules24091672","article-title":"Design, synthesis, and mechanism of dihydroartemisinin\u2212coumarin hybrids as potential anti-neuroinflammatory agents","volume":"24","author":"Yu","year":"2019","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-022-04233-2","article-title":"Comparison of LPS and MS-induced depressive mouse model: behavior, inflammation and biochemical changes","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J. Evid. Based Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/ijms23116354","article-title":"Artemisinin Attenuates amyloid-induced brain inflammation and memory impairments by modulating TLR4\/NF-\u03baB signaling","volume":"23","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.19540\/j.cnki.cjcmm.20180524.001","article-title":"Application of three artemisinin derivatives in neuropathic pain: evaluating co-curation of nociceptive and emotional syndromes in spinal cord ligation mice","volume":"43","author":"Zhu","year":"2018","journal-title":"Zhongguo Zhong Yao Za Zhi"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1916381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:48Z","timestamp":1791178368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1916381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":48,"alternative-id":["10.3389\/fphar.2026.1916381"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1916381","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1916381"}}